Complexation of calix[4]arene hydroxymethyl-phosphonic acid with tryptophan and N-acetyl-tryptophan amide

Authors

DOI:

https://doi.org/10.24959/ophcj.14.796

Keywords:

calixarene hydroxymethylphosphonic acid, tryptophan, N-acetyltryptophan amide, reversed-phase high performance liquid chromatography, supramolecular complexes, binding constants

Abstract

The Host-Guest complexation of calixarene hydroxymethylphosphonic acid with tryptophan and N-acetyltryptophan amide has been investigated by the RP HPLC method in H2O/MeCN (99/1) solution (column support Hypersil CN, UV-detector, λ = 254 nm). Adsorption of calixarene hydroxymethylphosphonic acid on the Hypersil CN surface has been studied. It has been found that hydroxymethylphosphonic acid is characterized by reversible sorption on the Hypersil CN surface. The binding constants (KA = 23000 M-1 and 39000 M-1 for tryptophan and N-acetyltryptophan amide, respectively) of the supramolecular complexes have been calculated from the ratio between the capacity factors k’ of the Guest and the calixarene hydroxymethylphosphonic acid Host concentration in the mobile phase. The Gibbs free energies of the tryptophan and N-acetyltryptophan amide complexes are -24.84 and -26.15 kJ/mol, respectively. The molecular modelling of calixarene hydroxymethylphosphonic acid and its complexes with tryptophan and N-acetyltryptophan amide (Hyper Chem, version 8, force field PM3) has indicated that the complexes are stabilized by hydrogen bonds, electrostatic, π-π, and solvatophobic interactions. The geometric parameters of the energy minimized calixarene macrocycle and its complexes with tryptophan and N-acetyltryptophan amide have been calculated. According to the calculations it has been shown that the Host-Guest complexation does not change the flattened-cone conformation of calixarene. Finally, the inverse correlation has been found between the KA values of the complexes and the Log P values of the guest molecules.

Downloads

Download data is not yet available.

References

  1. Kaneda Y., Tabata Y. Cancer Sci., 2006, Vol. 97, pp.348-354.
  2. De Guzman R.N., Wu Z.R., Stalling C.C., Pappalardo L., Borer P.N., Summers M.F. Science, 1998, Vol. 279, pp.384-388.
  3. Amarasinghe G.K., De Guzman R.N., Turner R.B., Chancellor K.J., Wu Z.R., Summers M.F. J. Mol. Biol., 2000, Vol. 301, pp.491-511.
  4. Bourbigot S., Ramalanjaona N., Boudier C., Gilmar F.J., Salgado R.B.P., Mely Y., Bouaziz S., Morellet N. J. Mol. Biol., 2008, Vol. 383, pp.1112-1128.
  5. Huili C., Pin Y. Progress in Chemistry, 2002, Vol. 14, pp.239-243.
  6. Gutsche C.D. Calixarenes Revisited, Cambridge, RSC, 1998.
  7. Sansone F., Segura M., Ungaro R. Calixarenes in bioorganic and biomimetic chemistry. In: Calixarenes 2001, Asfari M.-Z., Böhmer V., Harrowfield J., Vicens J. (eds.), Kluwer Academic Publishers, Dordrecht, 2001, pp.496-512.
  8. Casnati A., Sansone F., Ungaro R. Acc. Chem. Res., 2003, Vol. 36, pp.246-254.
  9. Perret F., Lazar A.N., Coleman A.W. Chem. Commun, 2006, pp.2425-2438.
  11. Coleman A.W., Perret F., Moussa A., Dupin M., Guo Y., Perron H. Top. Curr. Chem., 2007, Vol. 277, pp.31-88.
  12. Zadmard R., Schrader T. J. Am. Chem. Soc., 2005, Vol. 127, pp.904-915.
  13. Park H.S., Lin Q., Hamilton A.D. J. Am. Chem. Soc., 1999, Vol. 121, pp.8-13.
  14. Markovsky L.N., Kalchenko V.I., Solovyov A.V., Finocchiaro P., Failla S., Atamas L., Consiglio G., Tsymbal I.F. Anales de Quimica, 1998, Vol. 94, pp.164-170.
  15. Solovyov A.V., Cherenok S., Tsymbal I., Failla S., Consiglio G., Finocchiaro P., Kalchenko V.I. Heteroatom Chemistry, 2001, Vol. 12, pp.58-67.
  16. Cherenok S.O., Yushchenko O.A., Tanchuk V.Yu., Mischenko I.M., Samus N.V., Ruban, O.V., Matvieiev Yu.I., Karpenko J.A., Kukhar V.P., Vovk A.I., Kalchenko V.I. ARKIVOC, 2012, Vol. 15, pp.278-298.
  17. Zielenkiewicz W., Marcinowicz A., Poznanski J., Cherenok S., Kalchenko V. J. Incl. Phenom., 2006, Vol. 55, pp.11-19.
  18. Kalchenko O., Cherenok S., Yushchenko O., Kalchenko V. J. Incl. Phenom., 2013, Vol. 76, pp.29-36.
  19. Kalchenko O.I., Lipkowski J., Nowakowski R., Kalchenko V.I., Vysotsky M.A., Markovsky L.N. J. Incl. Phenom., 1998, Vol. 23, pp.377-380.
  21. Kalchenko O.I., Da Silva E., Coleman A.W. J. Incl. Phenom., 2002, Vol. 43, pp.305-310.

Downloads

Published

2014-06-10

How to Cite

(1)
Kalchenko, O. I.; Cherenok, S. O.; Rodik, R. V.; Mely, Y.; Klymchenko, A. S.; Gorbatchuk, V. V.; Kalchenko, V. I. Complexation of calix[4]arene Hydroxymethyl-Phosphonic Acid With Tryptophan and N-Acetyl-Tryptophan Amide. J. Org. Pharm. Chem. 2014, 12, 21-26.

Issue

Vol. 12 No. 2(46) (2014)

Section

Original Researches

License

Copyright (c) 2014 National University of Pharmacy

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors publishing their works in the Journal of Organic and Pharmaceutical Chemistry agree with the following terms:

1. Authors retain copyright and grant the journal the right of the first publication of the work under Creative Commons Attribution License allowing everyone to distribute and re-use the published material if proper citation of the original publication is given.

2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book) providing proper citation of the original publication.

3. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on authors’ personal websites) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).